Blog page Blog Expert opinions, data-driven insights, and smarter decisions Senior experts and board-certified physicians delivering seamless regulatory, medical, and safety leadership worldwide. CR-001 (SKB118) and the Disruption of Standard Care in Immuno-Oncology January 28, 2026 No Comments PD-1 x VEGF cooperative binding mechanism and its potential to dismantle the Pembrolizumab Standard of Care. Despite the success Read More » Follow us Follow us on LinkedIn for more updates. Follow Amodaia on LinkedIn
CR-001 (SKB118) and the Disruption of Standard Care in Immuno-Oncology January 28, 2026 No Comments PD-1 x VEGF cooperative binding mechanism and its potential to dismantle the Pembrolizumab Standard of Care. Despite the success Read More »